CAMBRIDGE, England--(BUSINESS WIRE)--Shift Bioscience, a biotech company using an AI powered virtual cell to fight age-related diseases, today announced the appointments of Jill Reckless, Ph.D, as ...
AI virtual cells outperform key baselines on well-calibrated metrics, challenging prior reports of poor model performance Foundational research reinforces the use of virtual cell models to accelerate ...
Shift Bioscience (Shift), a biotechnology company uncovering the biology of cell rejuvenation to develop new therapies for age driven diseases, today announced the results of a new study detailing an ...
Hosted on MSN
Shift Bioscience identifies novel single-gene target for safer cellular rejuvenation therapeutics
Shift Bioscience (Shift), a biotechnology company uncovering the biology of cell rejuvenation to develop new therapies for age driven diseases, today announced the publication of new research ...
Go to The Scientist's Facebook Page Go to The Scientist's Instagram Page Go to The Scientist's LinkedIn Page Go to The Scientist's Podcast Page Go to The Scientist's YouTube Page Effective gene ...
Shift Bioscience (Shift), a biotechnology company uncovering the biology of cell rejuvenation to end the morbidity and mortality of aging, today announced the release of new research detailing an ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results